Archives: Team

Medical Education

From 2000 to 2007, Dr. Jens Nolting completed his medical studies at the Albertus Magnus University of Cologne. During his studies, he gained extensive international clinical and scientific experience at institutions including the Royal Infirmary of Edinburgh, El Hospital Costa del Sol in Spain, and St. Luke’s Hospital in Malta. Particularly formative for his later specialization in translational and immune-based oncology were his stays at Hospital Civil Guadalajara and the National Cancer Institute in Mexico, as well as the renowned Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital in the USA.

Clinical Career

2007–2016

Dr. Jens Nolting completed his specialist clinical training at the Department of Hematology, Oncology, and Rheumatology at the University Hospital Bonn and at the Center for Integrated Oncology (CIO) Cologne/Bonn, a leading Comprehensive Cancer Center. There, he earned his specialist certifications in Internal Medicine, Hematology, and Oncology.

In 2013, he took on the leadership role as Principal Investigator at the Myeloma Research Center Bonn (MRCB), where he coordinated interdisciplinary research projects with industry-funded support from companies such as Celgene and Janssen Cilag.

Since 2017, Dr. Nolting has served as an oncologist at Hallwang Clinic.

Specialization

Dr. Nolting combines clinical excellence with translational research and is recognized as a distinguished expert in the fields of immuno-oncology, cancer immunology, and molecular oncology. He has a particular interest in the research and development of personalized, immune-based cancer therapies that specifically address the biological characteristics of individual tumors. His focus lies on the complex interactions within the tumor microenvironment and the role of regulatory T-cells in cancer defense. With his integrative approach, Dr. Nolting unites clinical experience and scientific innovation to develop and translate new therapeutic strategies for hematological diseases and solid tumors into practice.

Research

Dr. Jens Nolting has cultivated a long-standing, internationally shaped research career with a particular focus on the immunobiology of cancer.

Early in his studies, from 2002 to 2003, he was involved in experimental projects on molecular stem cell biology and pediatric oncology at institutions including the University Hospital Cologne and the Heinrich Heine Institute Düsseldorf. As part of his doctoral thesis from 2003 to 2006, he investigated the role of the tumor-specific antigen PRAME in neuroblastoma cells.

From 2007 to 2009, Dr. Nolting worked as a postdoctoral researcher at the Dana-Farber Cancer Institute of Harvard Medical School. There, in the renowned Laboratory for Cancer Immunology and AIDS under the direction of Prof. Dr. Dr. h.c. Harald von Boehmer, he investigated fundamental mechanisms of T-cell regulation. He gained further research experience at Johns Hopkins Hospital in Baltimore in the working group of Prof. Dr. Arceci, a renowned expert in pediatric oncology.

In 2013, Dr. Nolting was admitted to the German Research Foundation’s Collaborative Research Center 832, which focused on the molecular modulation of the tumor microenvironment. In the same year, he took over the leadership of the Myeloma Research Center Bonn (MRCB), where he was responsible for industry-funded research collaborations with Celgene and Janssen and significantly contributed to the development of innovative immunotherapies.

Publications

Dr. Jens Nolting has authored numerous scientific publications in high-ranking specialist journals, reflecting his interdisciplinary expertise and focus on immuno-oncology. His work has appeared in publications such as Nature Immunology, Immunity, Journal of Experimental Medicine, Leukemia, Cancer Immunology, Immunotherapy, and Translational Oncology.

His contributions span topics from the role of regulatory T-cells in tumor defense and mechanisms of the tumor microenvironment to innovative drug approaches for various cancer types, including multiple myeloma, melanoma, pancreatic, breast, and ovarian cancer.Of particular note is his co-authorship on an Immunity study concerning β2-microglobulin and the NLRP3 inflammasome in tumor-associated macrophages, as well as his research on BET inhibitors, CDK5, and liposomal curcumin analogs as new therapeutic options. This work makes a significant contribution to the development of targeted and immune-based therapies in modern oncology.

Awards

2013: Else Kröner-Fresenius Foundation Scholarship

1999: Foundation Chemistry Award

Additionally, Dr. Nolting has received peer-reviewed funding from Bonfor, the German Research Foundation (DFG), and the Else Kröner Research Foundation – a testament to his scientific excellence and innovative power.

Medical Education

Dr. Ali Alreda Zarouff completed his medical education at the University of Damascus, Syria, where he studied medicine from 1996 to 2002, earning his Doctor of Medicine (MD). Under the supervision of Prof. Hamud Naser, he authored a dissertation titled “Novelty Diagnostics and Therapeutics in Breast Diseases” in the field of general surgery, published in June 2002. With Arabic and English as his primary languages of study, Dr. Zarouff undertook extensive examinations, including the Arab Board of Internal Medicine (2002 and 2007) and the USMLE exams in the United States, achieving exceptional scores (Step 1: 90%, Step 2: 96%). He pursued his specialist training in internal medicine and hematology/oncology in Germany, where he also obtained his medical license.

Clinical Career

2010–2013

Dr. Ali Zarouff began his career as a resident in internal medicine, initially working in the emergency department of Damascus Hospital, followed by roles in hematology at Almuassah University Hospital and cardiology at the Syrian Arab Red Crescent Hospital. He further expanded his expertise in various areas of internal medicine, including gastroenterology, rheumatology, pulmonology, nephrology, and neurology, at Damascus Hospital. Building on this foundation, he specialized as a fellow in oncology at Beiruni University Hospital and continued his hematology-oncology training at Damascus Hospital, later advancing his education at the University Clinic of Marburg and St. Marien Hospital in Siegen, Germany.

2014–2015

In Germany, he continued his career as a specialist in hematology and oncology at St. Marien Hospital, Siegen, and later as a senior oncologist at St. Bonifatius Hospital, Lingen.

2015–2020

In 2015, Dr. Zarouff joined the Hallwang Clinic as a Senior Specialist Registrar. He then became Head of the Hematology-Oncology Department at Helios-Hanseklinikum Stralsund in 2018 and served as an Assistant Consultant for Hematology-Oncology at Klinikum Gütersloh from 2019 to 2020.

Since 2020, Dr. Zarouff has been an oncologist at the Hallwang Clinic.

Specialization

Dr. Zarouff possesses extensive experience in treating patients with hematological and oncological conditions. He has diagnosed and treated over 2,500 patients in these areas and has profound expertise in ultrasound diagnostics, particularly for the thyroid, axillary lymph nodes, neck, abdomen, and legs. Additionally, he is specialized in the preparation and administration of stem cell transplants, including high-dose chemotherapy and follow-up care. Dr. Zarouff is also proficient in cytogenetic diagnostics (FISH), molecular biology, and cytology.

Research

Dr. Zarouff began his scientific career with his dissertation on “Novelty Diagnostics and Therapeutics in Breast Diseases”at the University of Damascus in 2002. Throughout his career, he has participated in numerous advanced training programs and professional congresses, including the DGHO Congress in Basel (2015) and Vienna (2013), as well as courses in cytogenetics, molecular biology, and microscopy in Germany. His scientific work focuses on advancing diagnostic and therapeutic methods in oncology, particularly in hematology and solid tumors.

Publications

Dr. Zarouff published his dissertation, titled “New in Breast Diseases,” in 2002 at the University of Damascus. He has attended several international congresses and professional courses to present his research findings and insights in oncology.

Medical Education

Greg Schwarz studied medicine from 1984 to 1989 at the University of Tasmania, where he earned his Bachelor of Medical Science (B.Med.Sci.) in 1986 and Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1989. He continued his studies from 1997 to 2000, completing a Master of Science in Environmental Management at the University of Tasmania. In 2004, he obtained a Fellowship with the Australasian College of Nutritional and Environmental Medicine (FACNEM) and later attended the IFM ReCODE training program in Miami, USA, in 2017 and 2023.

Clinical Career

1991–1995

As a Resident Medical Officer at the Royal Hobart Hospital, Greg Schwarz completed the surgical training program, gaining extensive experience in various surgical specialties. He subsequently continued his career as a general practitioner in both rural and urban practices across Tasmania.

1995–1996

He undertook surgical locums in England and expanded his expertise as a Senior House Officer in Anesthetics and Intensive Care at Glan Clwydd Hospital in Wales.

1997–2010

Returning to Tasmania, he specialized in general practice with a focus on Functional and Integrative Medicine.

Since 2010, he has been practicing at the Hallwang Private Oncology Clinic.

Specialization

Greg Schwarz specializes in Functional and Integrative Medicine, a holistic healthcare approach that integrates both conventional and alternative practices to address the root causes of diseases and optimize health.

Research

Throughout his scientific career, Greg Schwarz has focused on environmental medicine and integrative approaches to patient care. His Master of Science in Environmental Management provided a strong foundation in understanding environmental factors and their impacts on health. His Fellowship with the Australasian College of Nutritional and Environmental Medicine further advanced his expertise in nutritional and environmental medicine, while his participation in the IFM ReCODE program expanded his knowledge in treating neurodegenerative diseases within a functional medicine context.

Publications

Over the course of his career, Greg Schwarz has published multiple works on topics including environmental medicine, nutritional medicine, and integrative medicine. His writings primarily explore the connections between environmental factors and health, as well as holistic treatment methods.

Medical Education

Dr. Natalia Fedorova completed her medical studies at the State Medical Academy in Chelyabinsk, Russia, from 1995 to 2001, followed by a two-year residency in oncology at the same institution. Her medical training includes an initial specialization in clinical radiology and chemotherapy (2004) at the Russian Medical Academy in Moscow, an advanced course on oncology emergencies (2005), and an initial specialization in clinical dermatology (2007). She also undertook several internships, including in chemotherapy at the Sanafontis Clinic in Freiburg (2009) and in laser medicine at the Avantgarde Center for Laser Medicine and Dermatology in Berlin (2010). In 2010, she earned her PhD in Oncology from the State Medical University in Ufa, Russia, with her dissertation on “The Tactics of Diagnosis and Treatment of Patients with Metastatic Cervical Lymph Node Involvement from an Unknown Primary Tumor.”

Clinical Career

2003–2007

Assistant Physician in Radiology and Oncology at the State Oncology Center in Chelyabinsk. Responsibilities included internal medicine, oncology, dermatology, radiotherapy, and emergency therapy. She participated in multidisciplinary tumor boards and clinical studies.

2007–2009

Specialist in Oncology in the oncology department of Medicina ISC Clinic in Moscow. Specializations included internal medicine, oncology, dermatology, and palliative care.

2009–2014

Specialist in Oncology and Medical Director of the private oncology Berkana Clinic in Moscow. Responsibilities encompassed internal medicine, oncology, dermatology, emergency therapy, and management.

2015–2016

Scientific Assistant in the private oncology practice Unifontis in Tübingen, focusing on internal medicine, oncology, unconventional therapies, and palliative care.

Since 2018, Dr. Fedorova has been a medical assistant at the Hallwang Clinic.

Specialization

Dr. Fedorova specializes in oncology and has profound expertise in clinical radiology, chemotherapy, dermatology, and breast cancer treatment. Additionally, she has significant experience in photodynamic diagnostics and therapy as well as palliative medicine.

Research

Dr. Fedorova has focused her scientific career on oncology. Her dissertation addressed the diagnosis and treatment of patients with metastatic cervical lymph node involvement from an unknown primary tumor. She has actively participated in clinical trials and multidisciplinary research projects. During her time as a scientific assistant and physician, she has made significant contributions to unconventional cancer therapies and palliative care methods.

Publications

Dr. Fedorova is the co-author of 25 publications, has written 60 articles, published 10 clinical case studies, and presented her own research findings in 8 publications. She also holds two patents.